Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • quant
    Junior Member
    • Jun 2010
    • 7

    #1

    Bioinformatics Core Facility position in Mainz, Germany

    IMB is in its start-up phase and there are many opportunities for outstanding and ambitious young scientists to join us as group leaders, postdocs or PhD students.



    Bioinformatician (m/f)


    The Institute of Molecular Biology gGmbH (IMB) is a Centre of Excellence for Life Sciences funded by the Boehringer Ingelheim Foundation and located within the campus of the University of Mainz in Germany. IMB focuses on epigenetics, DNA repair and developmental biology and offers premium scientific core facilities (see www.imb-mainz.de/core-facilities).

    The Bioinformatics Core Facility supports the IMB researchers and external collaborators in performing high-throughput data processing, analysis, visualisation and interpretation, as well as by providing IT infrastructure, teaching and consulting services. We are looking for a highly motivated Bioinformatician (m/f) with enthusiasm for academic and translational biomedical research to join our team.


    You will:

    · Support biomedical scientists in the experimental planning, processing, analysis and publication of transcriptomic and epigenomic next-generation sequencing (NGS) data
    · Analyse and integrate various “omics” datasets for solving complex scientific questions
    · Contribute to the development of NGS analysis workflows and pipelines


    Required qualifications:

    · University degree or postgraduate training in computational biology / bioinformatics
    · Extensive (2+ years) experience in the analysis of NGS data, particularly ChIP-seq and RNA-seq
    · Solid programming skills in scripting and/or compiled languages
    · Familiarity with Linux / Unix environment and compute clusters
    · Sound knowledge of statistics and R / Bioconductor
    · Proficiency in written and spoken English
    · Good organisational, communication and interpersonal skills


    Desirable qualifications:

    · Experience in interdisciplinary collaborations or bioinformatics services
    · Familiarity with contemporary biomedical topics and translational research


    We offer:

    · Involvement in exciting projects in molecular biology and translational epigenetics
    · Stimulating, diverse and international research environment
    · Flexible working hours and advanced training opportunities
    · Competitive salary and favourable pension scheme

    IMB is an equal opportunity employer.

    Applications should be in English and sent as a single PDF file including a cover letter, CV, certificates and contact information of at least two professional references quoting Ref. No. CFBIO09 to personal(at)imb-mainz.de.

    Starting date: First half of 2016 with an initial contract for 2 years including an option for Extension.

    Deadline for applications: 31st January 2016

    IMB is in its start-up phase and there are many opportunities for outstanding and ambitious young scientists to join us as group leaders, postdocs or PhD students.

Latest Articles

Collapse

  • SEQadmin2
    16S/ITS Profiling vs. Shotgun Metagenomics: What Changes in Your Workflow?
    by SEQadmin2




    NGS has revolutionized clinical microbiology by offering new ways to identify and surveil pathogens without prior knowledge of the target. One popular approach is 16S rRNA and ITS amplicon sequencing, which targets specific microbial markers. But studies are increasingly incorporating shotgun metagenomics, a technique that sequences all DNA from a sample without targeting specific microbial markers. This approach allows more detailed taxonomic classification, detection...
    Yesterday, 06:46 AM
  • SEQadmin2
    Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
    by SEQadmin2



    Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

    Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
    ...
    10-14-2026, 09:55 AM

ad_right_rmr

Collapse

News

Collapse

Topics Statistics Last Post
Started by SEQadmin2, 10-28-2026, 09:57 AM
0 responses
28 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-28-2026, 09:51 AM
0 responses
18 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-22-2026, 11:13 AM
0 responses
71 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-22-2026, 10:48 AM
0 responses
48 views
0 reactions
Last Post SEQadmin2  
Working...